Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Anatomic Stage III Breast Cancer AJCC v8

Breast Neoplasms, Ovarian Neoplasms, Small Cell Lung Carcinoma

Breast Neoplasms

Locoregional Recurrence

Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Cancer Female

Carcinoma, Intraductal, Noninfiltrating

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Ovarian Neoplasms

Endometrial Neoplasms

Breast Neoplasms

Advanced Breast Carcinoma

Breast Cancer Metastatic

Breast Neoplasms

Endometrial Stromal Tumors

Breast Neoplasms

Endometrial Neoplasms

Endometrial Neoplasms

Low-Grade Serous Ovarian Cancer

Breast Neoplasms

Breast Neoplasms

Clinical Trials

KAT6

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

PF-07104091 as a Single Agent and in Combination Therapy

OMAHA-015

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

RaPhLRR

LaPemERLA

ADEPT

Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer

A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer

NeoMARS

Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

I-SPY

CARABELA

FELINE

BOUQUET

Abemaciclib and Letrozole to Treat Endometrial Cancer

Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

AMEERA-3

NELOPHER

BFR-ESS

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma

ALPINE: Maintenance Letrozole/Abemaciclib

CHAMELEON

Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer

NAOMI